Lung Cancer
In the past, treating blood cancer almost always involved chemotherapy, which was delivered through an IV at a doctor’s office or hospital. However, in recent years, researchers and scientists have developed cancer medications in pill form, which means that many patients with diseases such as lymphoma and leukemia are now treated with oral medications—tablets and capsules—that they take at home. Read More ›
Patients with ALK-positive (ALK+) non–small-cell lung cancer (NSCLC) whose cancer had spread to the brain responded well to the ALK inhibitor ceritinib, regardless of what prior cancer treatment they had received. This research was recently presented at the 2019 European Society for Medical Oncology Congress in Barcelona by Laura Chow, MD, from Dell Medical School at The University of Texas at Austin. Read More ›
Laura Greco, a mother of 4, was shocked when a CT scan done after a car accident revealed that she had stage III non–small-cell lung cancer with ALK mutation. Now she works as a patient advocate to fight the stigma linked to lung cancer, which often results in late diagnosis and worse outcomes. Read More ›
By Dan Dean
“Lung cancer”—what first pops into your head when you hear that? Read More ›
By Dawn Newton
Dawn Newton, a non-smoker diagnosed with lung cancer, chronicles her emotions as she spends time at the reception area before routine testing and while awaiting the results, knowing that at some point her cancer will stop responding to treatment. Read More ›
Dr. Bruce Gershenhorn explores 3 questions patients should ask after learning they have lung cancer. Knowledge is power. Read More ›
By Jane Morgan
Several immune checkpoint inhibitors are now approved for patients with non–small-cell lung cancer, giving hope to patients living with this disease. Read More ›
